The Russian drug Sputnik V has risen to the second place among coronavirus vaccines in terms of the number of countries that have approved it, overtaking Pfizer. This is stated in a post on the vaccine’s official Twitter account.
The first place in the world in terms of the number of countries that have agreed on the use of the drug is now occupied by the AstraZeneca vaccine, licensed in 49 countries, followed by Sputnik V with 45 countries. Pfizer ranks third (43 countries). This is followed by the Moderna vaccine (19 countries), as well as three Chinese vaccines – Sinopharm (18), Sinovac (16), CanSino (4). The Johnson & Johnson vaccine ranks eighth, it has been approved by 4 countries.